Based on its increased levels and association with poor survival in many different cancer types, ZFX does not appear to be a tumor type-specific oncogene, but rather increased levels of ZFX (and perhaps also ZFY and ZNF711) may generally contribute to metaplastic transformation via causing tumor-promoting changes in the transcriptome. The gene discussed is ZFX; the disease is neoplasm.